Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes

Aleshkov, 1997, Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer’s disease, Biochemistry, 36, 10571, 10.1021/bi9626362 Anthopoulos, 2010, Apolipoprotein E polymorphisms and type 2 diabetes: a meta-analysis of 30 studies including 5423 cases and 8197 controls, Mol. Genet. Metab., 100, 283, 10.1016/j.ymgme.2010.03.008 Baldwin, 1980, Regulation of insulin receptors: evidence for involvement of an endocytotic internalization pathway, Proc. Natl. Acad. Sci. USA, 77, 5975, 10.1073/pnas.77.10.5975 Beitner, 1971, Stimulation of glycolysis by insulin, J. Biol. Chem., 246, 500, 10.1016/S0021-9258(18)62516-5 Biessels, 2006, Risk of dementia in diabetes mellitus: a systematic review, Lancet Neurol., 5, 64, 10.1016/S1474-4422(05)70284-2 Bomfim, 2012, An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease- associated Aβ oligomers, J. Clin. Invest., 122, 1339, 10.1172/JCI57256 Bu, 2009, Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy, Nat. Rev. Neurosci., 10, 333, 10.1038/nrn2620 Bu, 1995, 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein, EMBO J., 14, 2269, 10.1002/j.1460-2075.1995.tb07221.x Calero, 2000, Apolipoprotein J (clusterin) and Alzheimer’s disease, Microsc. Res. Tech., 50, 305, 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L Carpentier, 1978, 125I-insulin binding to cultured human lymphocytes. Initial localization and fate of hormone determined by quantitative electron microscopic autoradiography, J. Clin. Invest., 61, 1057, 10.1172/JCI109005 Cataldo, 2000, Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer’s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations, Am. J. Pathol., 157, 277, 10.1016/S0002-9440(10)64538-5 Chan, 2015, Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice, Sci. Rep., 5, 13842, 10.1038/srep13842 Chan, 2016, ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing Aβ impairment of insulin signaling in an Alzheimer’s disease mouse model, Sci. Rep., 6, 26119, 10.1038/srep26119 Chen, 2010, ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling, Proc. Natl. Acad. Sci. USA, 107, 12011, 10.1073/pnas.0914984107 Cihil, 2013, The cell-based L-glutathione protection assays to study endocytosis and recycling of plasma membrane proteins, J. Vis. Exp., e50867 Claxton, 2013, Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer’s disease, J. Alzheimers Dis., 35, 789, 10.3233/JAD-122308 Claxton, 2015, Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer’s disease dementia, J. Alzheimers Dis., 44, 897, 10.3233/JAD-141791 Cohen, 2001, The renaissance of GSK3, Nat. Rev. Mol. Cell Biol., 2, 769, 10.1038/35096075 Craft, 2009, The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged, Arch. Neurol., 66, 300, 10.1001/archneurol.2009.27 Craft, 2004, Insulin and neurodegenerative disease: shared and specific mechanisms, Lancet Neurol., 3, 169, 10.1016/S1474-4422(04)00681-7 Craft, 2000, Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer’s disease differ according to apolipoprotein-E genotype, Ann. N Y Acad. Sci., 903, 222, 10.1111/j.1749-6632.2000.tb06371.x Craft, 2013, Insulin and Alzheimer’s disease: untangling the web, J. Alzheimers Dis., 33, S263 David, 2010, Widespread protein aggregation as an inherent part of aging in C. elegans, PLoS Biol., 8, e1000450, 10.1371/journal.pbio.1000450 De Felice, 2014, Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease, Diabetes, 63, 2262, 10.2337/db13-1954 DeFronzo, 2009, Skeletal muscle insulin resistance is the primary defect in type 2 diabetes, Diabetes Care, 32, S157, 10.2337/dc09-S302 Di Guglielmo, 1998, Insulin receptor internalization and signalling, Mol. Cell. Biochem., 182, 59, 10.1023/A:1006883311233 Ding, 2016, Low-density lipoprotein receptor-related protein-1 protects against hepatic insulin resistance and hepatic steatosis, EBioMedicine, 7, 135, 10.1016/j.ebiom.2016.04.002 Ehlers, 2000, Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting, Neuron, 28, 511, 10.1016/S0896-6273(00)00129-X Elliott, 2010, Apolipoprotein-E forms dimers in human frontal cortex and hippocampus, BMC Neurosci., 11, 23, 10.1186/1471-2202-11-23 Fu, 2016, Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan, Mol. Neurodegener., 11, 37, 10.1186/s13024-016-0099-y García-Cáceres, 2016, Astrocytic insulin signaling couples brain glucose uptake with nutrient availability, Cell, 166, 867, 10.1016/j.cell.2016.07.028 Ginsberg, 2010, Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer’s disease, J. Alzheimers Dis., 22, 631, 10.3233/JAD-2010-101080 Gorden, 1978, Intracellular translocation of iodine-125-labeled insulin: direct demonstration in isolated hepatocytes, Science, 200, 782, 10.1126/science.644321 Grbovic, 2003, Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production, J. Biol. Chem., 278, 31261, 10.1074/jbc.M304122200 Hatters, 2006, Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils, J. Mol. Biol., 361, 932, 10.1016/j.jmb.2006.06.080 Heeren, 2004, Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation, J. Biol. Chem., 279, 55483, 10.1074/jbc.M409324200 Ho, 2004, Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease, FASEB J., 18, 902, 10.1096/fj.03-0978fje Hoyer, 2004, Glucose metabolism and insulin receptor signal transduction in Alzheimer disease, Eur. J. Pharmacol., 490, 115, 10.1016/j.ejphar.2004.02.049 Jack, 2010, Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade, Lancet Neurol., 9, 119, 10.1016/S1474-4422(09)70299-6 Kim, 2009, Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes, Endocrinology, 150, 5294, 10.1210/en.2009-0695 Kim, 2009, The role of apolipoprotein E in Alzheimer’s disease, Neuron, 63, 287, 10.1016/j.neuron.2009.06.026 Kublaoui, 1995, Dynamics of signaling during insulin-stimulated endocytosis of its receptor in adipocytes, J. Biol. Chem., 270, 59, 10.1074/jbc.270.1.59 Lane-Donovan, 2014, More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration, Neuron, 83, 771, 10.1016/j.neuron.2014.08.005 Lane-Donovan, 2016, Genetic restoration of plasma ApoE improves cognition and partially restores synaptic defects in ApoE-deficient mice, J. Neurosci., 36, 10141, 10.1523/JNEUROSCI.1054-16.2016 Lindner, 2009, Protein aggregation as a paradigm of aging, Biochim. Biophys. Acta, 1790, 980, 10.1016/j.bbagen.2009.06.005 Liu, 2013, Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy, Nat. Rev. Neurol., 9, 106, 10.1038/nrneurol.2012.263 Liu, 2015, Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain, J. Neurosci., 35, 5851, 10.1523/JNEUROSCI.5180-14.2015 Liu, 2016, Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer’s disease, Sci. Transl. Med., 8, 332ra44, 10.1126/scitranslmed.aad3650 Martel, 1997, Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer’s amyloid beta, J. Neurochem., 69, 1995, 10.1046/j.1471-4159.1997.69051995.x Michael, 2000, Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction, Mol. Cell, 6, 87, 10.1016/S1097-2765(05)00015-8 Morikawa, 2005, Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta, Neurobiol. Dis., 19, 66, 10.1016/j.nbd.2004.11.005 Morrow, 2002, Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease, J. Biol. Chem., 277, 50380, 10.1074/jbc.M204898200 Nisr, 2014, Insulin acutely improves mitochondrial function of rat and human skeletal muscle by increasing coupling efficiency of oxidative phosphorylation, Biochim. Biophys. Acta, 1837, 270, 10.1016/j.bbabio.2013.10.012 Nixon, 2005, Endosome function and dysfunction in Alzheimer’s disease and other neurodegenerative diseases, Neurobiol. Aging, 26, 373, 10.1016/j.neurobiolaging.2004.09.018 Ong, 2014, Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice, Sci. Rep., 4, 3754, 10.1038/srep03754 Ott, 1999, Diabetes mellitus and the risk of dementia: The Rotterdam Study, Neurology, 53, 1937, 10.1212/WNL.53.9.1937 Peila, 2002, Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study, Diabetes, 51, 1256, 10.2337/diabetes.51.4.1256 Reger, 2006, Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype, Neurobiol. Aging, 27, 451, 10.1016/j.neurobiolaging.2005.03.016 Reger, 2008, Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults, J. Alzheimers Dis., 13, 323, 10.3233/JAD-2008-13309 Reiman, 1996, Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E, N. Engl. J. Med., 334, 752, 10.1056/NEJM199603213341202 Reiman, 2005, Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism, Proc. Natl. Acad. Sci. USA, 102, 8299, 10.1073/pnas.0500579102 Sims-Robinson, 2010, How does diabetes accelerate Alzheimer disease pathology?, Nat. Rev. Neurol., 6, 551, 10.1038/nrneurol.2010.130 Small, 1995, Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease, JAMA, 273, 942, 10.1001/jama.1995.03520360056039 Steen, 2005, Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease--is this type 3 diabetes?, J. Alzheimers Dis., 7, 63, 10.3233/JAD-2005-7107 Talbot, 2012, Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline, J. Clin. Invest., 122, 1316, 10.1172/JCI59903 Trischitta, 1989, Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase, J. Biol. Chem., 264, 5041, 10.1016/S0021-9258(18)83696-1 Unger, 1991, Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects, Prog. Neurobiol., 36, 343, 10.1016/0301-0082(91)90015-S Weisgraber, 1991, Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity, J. Biol. Chem., 266, 12029, 10.1016/S0021-9258(18)99060-5 Willette, 2015, Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease, JAMA Neurol., 72, 1013, 10.1001/jamaneurol.2015.0613 Winzell, 2004, The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes, Diabetes, 53, S215, 10.2337/diabetes.53.suppl_3.S215 Xu, 2006, Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus, J. Neurosci., 26, 4985, 10.1523/JNEUROSCI.5476-05.2006 Xu, 2016, Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration, J. Clin. Invest., 126, 1815, 10.1172/JCI82409 Zhang, 2012, Measuring energy metabolism in cultured cells, including human pluripotent stem cells and differentiated cells, Nat. Protoc., 7, 1068, 10.1038/nprot.2012.048 Zhao, 2009, Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric abeta, J. Biol. Chem., 284, 18742, 10.1074/jbc.M109.011015 Zhao, 2017, Apolipoprotein E, receptors, and modulation of Alzheimer’s disease, Biol. Psychiatry